Author Archives: Alfonso Aguaron

Module 6: Drug post-marketing follow up and pharmacovigilance

Introduction of drug post-marketing Usually, new drugs are approved based on the result of clinical research studies, also know as clinical trials, which involves relatively small number of patients selected for the purpose of assessing its safety and efficacy. Once these drugs are released on the market and prescribed to a higher number of people, a post-marketing follow up and […]

Read More

Module 5: Health Technology Assessment (HTA) and drug pricing

Introduction to pharmacoeconomics Pharmacoeconomics refers to the branch of health economics which measures and compares the costs involved in pharmaceutical products (typically drugs) and services. It takes into account the research investment, production, distribution, storage, pricing and further use by patients. Pharmacoeconomics is useful when assessing the affordability and value of accessing a drug prescribed to a determined subgroup of […]

Read More